Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

X4 Pharmaceuticals (XFOR) Non-cash Items (2018 - 2019)

X4 Pharmaceuticals' Non-cash Items history spans 2 years, with the latest figure at $7.2 million for Q2 2019.

  • For Q2 2019, Non-cash Items rose 3774.59% year-over-year to $7.2 million; the TTM value through Jun 2019 reached $7.2 million, up 3774.59%, while the annual FY2018 figure was $6.5 million, N/A changed from the prior year.
  • Non-cash Items reached $7.2 million in Q2 2019 per XFOR's latest filing, roughly flat from $7.2 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $27.4 million in Q1 2018 to a low of $185000.0 in Q2 2018.